FENC

Fennec Pharmaceuticals
$10.21
+$0.22 (+2.2%)Jul 27, 2026
5.6NeutralMoatMint rating

MoatMint rates Fennec Pharmaceuticals (FENC) 5.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 2.4 out of 10.

Key metrics

The numbers that frame FENC today
Market cap
$354.67M
P/E (TTM)
-42.3
EV / FCF
-54.4
Gross margin
92.2%
EV / Sales
6.2
ROIC
-23.2%
Div yield
0%
Debt / equity
0.0
52wk Low
$5.65
52wk High
$11.31

FENC stock rating

How FENC scores on quality, value, growth, momentum and financial health
5.6out of 10
Neutral overallHealthy business, expensive priceTop 44% of ~5,000 US stocks
QualityFair2.4/10
GrowthGreat8.7/10
MomentumGreat8.4/10
ValueFair3.3/10
Financial HealthGood6.2/10

Growth

Revenue and earnings trend for FENC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about FENC
Is Fennec Pharmaceuticals a good buy?
Hold. Fennec Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Fennec Pharmaceuticals is selling at a high price.
What is the market capitalization of FENC?
Fennec Pharmaceuticals's market capitalization is $354.67M.
What is the P/E ratio for FENC stock?
Fennec Pharmaceuticals's current P/E ratio is -42.3.
What is the 52-week high for FENC stock?
The 52-week high for Fennec Pharmaceuticals is $11.31. The current close of $10.21 is 9.7% below that high.
What is the 52-week low for FENC stock?
The 52-week low for Fennec Pharmaceuticals is $5.65. The current close of $10.21 is 80.7% above that low.
Does FENC stock pay dividends?
Fennec Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for FENC?
Fennec Pharmaceuticals's Debt / Equity ratio is 0.